COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02129049
Recruitment Status : Completed
First Posted : May 2, 2014
Last Update Posted : March 9, 2016
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

Brief Summary:
This pilot clinical trial studies the feasibility of a telephone-based educational intervention in improving communication between patients with stage 0-III cancer and their children. An educational program delivered by telephone may help parents talk with their school-age child about their cancer.

Condition or disease Intervention/treatment Phase
Breast Cancer Cervical Cancer Colon Cancer Leukemia Lymphoma Malignant Neoplasm Melanoma Rectal Cancer Other: educational intervention Behavioral: telephone-based intervention Other: questionnaire administration Not Applicable

Detailed Description:


I. Test the feasibility of the recruitment and study protocol.

II. Evaluate the short-term impact of the program on the diagnosed parents' and the parent's perceptions of their children's adjustment using a within group design (pre-posttest design).

III. To compare outcomes from the telephone-delivered program with outcomes obtained from the in-person program (between group design).


Participants complete the Enhancing Connections Telephone Program comprising 5, 1 hour educational telephone sessions over 3 months. During session 1, parents receive help defining the child's experience with the cancer as distinct from their own and ways to manage their own cancer-related emotions so that they do not emotionally flood the child. During session 2, parents receive assistance with developing skills to deeply listen and attend to the child's thoughts and feelings, complementing the parent's tendency to be a teacher, not a deep listener, of the child's thoughts, concerns, worries or understandings. During session 3, parents receive additional communication and parenting skills enabling them to initiate difficult cancer-related conversations and also interact with an upset child or one who is not forthcoming. During session 4, parents receive help focusing on and non-judgmentally interpreting the child's ways of coping with the cancer. It includes exercises that assist the parent to relinquish negative assumptions about the child's behavior related to the parent's cancer. Concurrently the session offers the ill parent ways to elicit their child's report of what the parent can do to assist the child cope with the child's cancer-related pressures. During session 5, parents focus on the gains they made in prior sessions and what they have accomplished, in their own words, in parenting their child about the cancer. The session also assists the ill parent to identify available resources that can be used after program completion to maintain the parent's newly acquired gains from the program.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 35 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Enhancing Connections Telephone Program: A Cancer Education Program for Parents
Study Start Date : April 2014
Actual Primary Completion Date : July 2015

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Supportive care (Enhancing Connections Telephone Program)
See Detailed Description.
Other: educational intervention
Participate in the Enhancing Connections Telephone Program
Other Name: intervention, educational

Behavioral: telephone-based intervention
Participate in the Enhancing Connections Telephone Program

Other: questionnaire administration
Ancillary studies

Primary Outcome Measures :
  1. Recruitment and retention, monitored by tracking detailed recruitment spreadsheets [ Time Frame: Up to 3 months ]
    Each referral source and method of referral will be monitored, including documenting reason for refusal. Four methods of recruitment will be monitored in order to know which method yields the highest enrollment: self-referral, provider referral, passive letter opt-in, and passive letter opt-out.

  2. Dosage and fidelity, monitored for each intervention session using Performance Checklists [ Time Frame: Up to 3 months ]
    Each audio-recorded intervention session will be reviewed against these checklists. Study participants' compliance with the in-session and at-home assignments will be monitored by the audio-recorded intervention sessions.

  3. Acceptability of the program, assessed from interview data obtained from the Exit interview and the Swanson Caring Professional Scale [ Time Frame: Up to 3 months ]
  4. Rate of receipt of mailed materials both to participants and from participants [ Time Frame: Up to 3 months ]
    Materials include signed consents, baseline data, and parent's educational materials.

  5. Duration of phone intervention sessions [ Time Frame: Up to 3 months ]
  6. Rate of success in scheduling and completing intervention sessions by telephone [ Time Frame: Up to 3 months ]
  7. Quality of data on baseline and post-intervention measures [ Time Frame: Up to 3 months ]
  8. Short-term impact of the program, evaluated by comparing the change in pre- and post-test scores on the standardized questionnaires [ Time Frame: Baseline up to 3 months ]
    Analysis of covariance (ANCOVA) will be used to test for significant differences between pre- and post-test scores, assuming the data meet the statistical assumptions. Baseline scores will serve as the covariate, along with empirical variables that are known to co-vary with parent and child functioning, e.g., length of time of diagnosis, type of medical treatment, adjuvant therapy, among others). Two-tailed tests of significance will be calculated, allowing us to evaluate any potential negative effects of the intervention.

  9. Impact of the telephone-delivered compared to the in-person delivered program [ Time Frame: Up to 3 months ]
    Linear mixed modeling will be used. Random effects models are based on Maximum Likelihood Estimation in which an iterative method estimates a trajectory for each study participant based on all available data for that participant supplemented by data obtained from the total sample.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Parents will be eligible if they have an initial diagnosis of non-metastatic cancer of any type (stage 0-3), including melanoma, colorectal, cervical, leukemia, lymphoma or breast cancer within the past 7 months
  • Read and write English among their languages of choice
  • Have ready access to a telephone
  • Have a child 5-12 years old living at home who has been told their parent's cancer diagnosis
  • The child is living at home and does not have learning challenges
  • No prior malignancy is allowed except for adequately treated basal (or squamous cell) skin cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT02129049

Layout table for location information
United States, Montana
Bozeman Deaconess Hospital
Bozeman, Montana, United States, 59715
United States, Washington
Columbia Basin Hematology and Oncology PLLC
Kennewick, Washington, United States, 99336
Tri-Cities Cancer Center
Kennewick, Washington, United States, 99336
SCCA at EvergreenHealth
Kirkland, Washington, United States, 98033
Skagit Valley Hospital
Mount Vernon, Washington, United States, 98274
Olympic Medical Center
Port Angeles, Washington, United States, 98362
Group Health Cooperative
Redmond, Washington, United States, 98052
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States, 98109
Swedish Cancer Institute
Seattle, Washington, United States, 98122-4307
Multicare Health System
Tacoma, Washington, United States, 98415
Wenatchee Valley Medical Center
Wenatchee, Washington, United States, 98801
Sponsors and Collaborators
University of Washington
National Cancer Institute (NCI)
Layout table for investigator information
Principal Investigator: Frances Lewis Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Layout table for additonal information
Responsible Party: University of Washington Identifier: NCT02129049    
Other Study ID Numbers: 9095
NCI-2014-00928 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )
9095 ( Other Identifier: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium )
R03CA178488 ( U.S. NIH Grant/Contract )
P30CA015704 ( U.S. NIH Grant/Contract )
First Posted: May 2, 2014    Key Record Dates
Last Update Posted: March 9, 2016
Last Verified: March 2016
Additional relevant MeSH terms:
Layout table for MeSH terms